<p>A and D: DFS (A) and OS (D) for TSCC and BOTSCC irrespective of the HPV status of the tumour. B and E: DFS (B) and OS (E) of patients with HPV-positive TSCC and BOTSCC. C and F: DFS (C) and OS (F) of patients with HPV-negative TSCC and BOTSCC.</p
<p>(A) PFS for patients with RRM1-negative tumors. (B) PFS for patients with RRM1-positive tumors.</...
<p>Data on 5-years Overall Survival and Trend test are shown according to each staging system for HP...
<p>Kaplan-Meier curves for disease-free survival by treatment arm are shown for patients with stage ...
<p>A and D: DFS (A) and OS (D) for TSCC and BOTSCC irrespective of the HPV status of the tumour. B a...
<p>A and D: DFS (A) and OS (D) for TSCC and BOTSCC irrespective of the HPV status of the tumour. B a...
<p>A) HPV<sup>+</sup>TSCC and B) HPV<sup>−</sup>TSCC patients stratified by the number of CD8<sup>+<...
<p>(<b>A</b>) Overall survival rate for 674 patients with LSCC (<b>B</b>) Progression-free survival ...
<p><i>A–B</i>, OS (<i>A</i>) and DFS (<i>B</i>) for the <i>MAML2</i> rearrangement. <i>C–D</i>, OS (...
<p>Kaplan-Meier curves on recurrence-free survival (A, B) and overall survival (C, D) according to t...
<p>(A) DFS stratified for HCA-2 intensity, (B) DSS stratified for HCA-2 intensity, (C) OS stratified...
<p><b>A,</b> Kaplan-Meier survival curves for OS in GC patients with LAPTM4B-35 positive and negativ...
<p><b>(A) Disease-free survival (DFS) based on the mtDNA somatic mutation status.</b> (B) Overall su...
<p>Kaplan-Meier survival curves of (A) progression-free survival (PFS) and (B) overall survival (OS)...
Kaplan-Meier survival curves for (A) the progression-free survival (PFS), and (B) the overall surviv...
<p>(A) Overall survival. (B) Progression-free survival. (C) Locoregional relapse-free survival and (...
<p>(A) PFS for patients with RRM1-negative tumors. (B) PFS for patients with RRM1-positive tumors.</...
<p>Data on 5-years Overall Survival and Trend test are shown according to each staging system for HP...
<p>Kaplan-Meier curves for disease-free survival by treatment arm are shown for patients with stage ...
<p>A and D: DFS (A) and OS (D) for TSCC and BOTSCC irrespective of the HPV status of the tumour. B a...
<p>A and D: DFS (A) and OS (D) for TSCC and BOTSCC irrespective of the HPV status of the tumour. B a...
<p>A) HPV<sup>+</sup>TSCC and B) HPV<sup>−</sup>TSCC patients stratified by the number of CD8<sup>+<...
<p>(<b>A</b>) Overall survival rate for 674 patients with LSCC (<b>B</b>) Progression-free survival ...
<p><i>A–B</i>, OS (<i>A</i>) and DFS (<i>B</i>) for the <i>MAML2</i> rearrangement. <i>C–D</i>, OS (...
<p>Kaplan-Meier curves on recurrence-free survival (A, B) and overall survival (C, D) according to t...
<p>(A) DFS stratified for HCA-2 intensity, (B) DSS stratified for HCA-2 intensity, (C) OS stratified...
<p><b>A,</b> Kaplan-Meier survival curves for OS in GC patients with LAPTM4B-35 positive and negativ...
<p><b>(A) Disease-free survival (DFS) based on the mtDNA somatic mutation status.</b> (B) Overall su...
<p>Kaplan-Meier survival curves of (A) progression-free survival (PFS) and (B) overall survival (OS)...
Kaplan-Meier survival curves for (A) the progression-free survival (PFS), and (B) the overall surviv...
<p>(A) Overall survival. (B) Progression-free survival. (C) Locoregional relapse-free survival and (...
<p>(A) PFS for patients with RRM1-negative tumors. (B) PFS for patients with RRM1-positive tumors.</...
<p>Data on 5-years Overall Survival and Trend test are shown according to each staging system for HP...
<p>Kaplan-Meier curves for disease-free survival by treatment arm are shown for patients with stage ...